000 01428 a2200421 4500
005 20250515080337.0
264 0 _c20071025
008 200710s 0 0 eng d
022 _a0176-3679
024 7 _a10.1055/s-2007-984399
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMolina, V
245 0 0 _aMarked hypofrontality in clozapine-responsive patients.
_h[electronic resource]
260 _bPharmacopsychiatry
_cJul 2007
300 _a157-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aCaudate Nucleus
_xdrug effects
650 0 4 _aClozapine
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFluorodeoxyglucose F18
_xpharmacokinetics
650 0 4 _aFollow-Up Studies
650 0 4 _aFrontal Lobe
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aPositron-Emission Tomography
650 0 4 _aPrefrontal Cortex
_xdrug effects
650 0 4 _aRadiopharmaceuticals
_xpharmacokinetics
650 0 4 _aSchizophrenia
_xdiagnostic imaging
650 0 4 _aThalamus
_xdrug effects
700 1 _aSanz, J
700 1 _aSarramea, F
700 1 _aPalomo, T
773 0 _tPharmacopsychiatry
_gvol. 40
_gno. 4
_gp. 157-62
856 4 0 _uhttps://doi.org/10.1055/s-2007-984399
_zAvailable from publisher's website
999 _c17226079
_d17226079